The American Institute of Cancer Research recommends a diet filled with a variety of fruits, vegetables, grains and ...

Researchers found that the Wnt5a protein, secreted by inflammatory fibroblasts within cancerous tumors, inhibits angiogenesis and consequently promotes hypoxia within tumors. Hypoxic conditions help ...

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Obesity is not just a cosmetic issue—it is a clinical and biological risk factor and progression driver for ovarian cancer ...

Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will ...

Exosomes transform prostate cancer care with early detection, tailored treatments, and real-time prognosis tracking for ...

Breast cancer remains a leading cause of cancer-related mortality globally, underscoring the critical need for early ...

Furthermore, SU11657 reduced tumor angiogenesis by 63–96%. Our experimental data suggest that the angiogenesis inhibitor SU11657 may be beneficial in the treatment of rapidly growing and highly ...

A new review in Genes and Diseases explores the central role of MYC, a master regulatory protein, in the development and progression of cancer, spotlighting its potential as a multidimensional ...

Prostate cancer (PCa) remains a leading cause of cancer-related mortality globally, with late-stage diagnoses contributing to ...

US pharma major Pfizer (NYSE: PFE) is stepping up its presence in the high-stakes field of bispecific immuno-oncology with a ...